Abstract
Falls are a major problem in dementia with an annual reported incidence of about 70–80 %, double that of older adults without cognitive impairment. Remaining mobile and free from falls is a priority, and understanding falls in dementia is of critical importance to mitigate the burden caused not only to the patient but also the carer. Despite this, there is currently no convincing evidence to mitigate falls risk in dementia. Gait and balance impairments are important falls risk factors as are cognitive impairment, and more recently the interdependency between these features has been recognized and is influencing assessment and the development of novel therapeutic strategies. This chapter covers four relevant and important key areas: (1) prevalence, incidence, and risk of falls with respect to different types of dementia including a focus on disorders in gait and balance which are important contributors and medication; (2) emerging evidence for contributory mechanisms; (3) evolving concepts relating to the interrelationship between gait, balance, cognition, and falls; and finally (4) approaches to mitigate falls risk and implications for clinical practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abellan van Kan G. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people. J Nutr Health Aging. 2009;13(10):881–9.
Allan LM, et al. Prevalence and severity of gait disorders in Alzheimer’s and non-Alzheimer’s dementias. J Am Geriatr Soc. 2005;53(10):1681–7.
Allan LM, et al. Incidence and prediction of falls in dementia: a prospective study in older people. PLoS One. 2009;4(5):e5521.
Allcock LM, et al. Impaired attention predicts falling in Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(2):110–5.
Ambrose AF, Paul G, Hausdorff JM. Risk factors for falls among older adults: a review of the literature. Maturitas. 2013;75(1):51–61.
American Geriatric Society/British Geriatric Society. Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc. 2011;591(1):148–57.
Annweiler C, et al. Contribution of brain imaging to the understanding of gait disorders in Alzheimer’s disease: a systematic review. Am J Alzheimers Dis Other Demen. 2012;27(6):371–80.
Assal F, et al. Galantamine improves gait performance in patients with Alzheimer’s disease. J Am Geriatr Soc. 2008;56(5):946–7.
Baezner H, et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology. 2008;70(12):935–42.
Bharwani G, et al. Individualized behavior management program for Alzheimer’s/dementia residents using behavior-based ergonomic therapies. Am J Alzheimers Dis Other Demen. 2012;27(3):188–95.
Blahak C, et al. Association of gait and balance disorders with age-related white mater changes: the LADIS study. Neurology. 2008;70:935–42.
Blankevoort CG, et al. Review of effects of physical activity on strength, balance, mobility and ADL performance in elderly subjects with dementia. Dement Geriatr Cogn Disord. 2010;30(5):392–402.
Bohnen NI, Albin RL. The cholinergic system and Parkinson disease. Behav Brain Res. 2011;221(2):564–73.
Bohnen NI, et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 2009a;73(20):1670–6.
Bohnen NI, et al. Age-associated leukoaraiosis and cortical cholinergic deafferentation. Neurology. 2009b;72(16):1411–6.
Bohnen NI, et al. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson’s disease. Brain. 2011;134(Pt 8):2358–65.
Burn DJ, et al. Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord. 2003;18(8):884–9.
Burn DJ, et al. Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77(5):585–9.
Camicioli R, Majumdar SR. Relationship between mild cognitive impairment and falls in older people with and without Parkinson’s disease: 1-year Prospective Cohort Study. Gait Posture. 2010;32(1):87–91.
Chung KA, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. 2010;75(14):1263–9.
Coupland C, et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551–66.
Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people – a review of the evidence. CNS Drugs. 2003;17(11):825–37.
de Laat KF, et al. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain. 2011;134(Pt 1):73–83.
Department of Health. Improving care for people with dementia. 2013. https://www.gov.uk/government/policies/improving-care-for-people-with-dementia.
Dobson R, et al. Bone health in chronic neurological diseases: a focus on multiple sclerosis and Parkinsonian syndromes. Pract Neurol. 2013;13(2):70–9.
Ensrud KE, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50(10):1629–37.
Eriksson S, Gustafson Y, Lundin-Olsson L. Risk factors for falls in people with and without a diagnosis of dementia living in residential care facilities: a prospective study. Arch Gerontol Geriatr. 2008;46(3):293–306.
Ferri C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–7.
Fick D, Kolanowski A, Waller J. High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period. Aging Ment Health. 2007;11(5):588–95.
Gillespie LD, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2009;2, CD007146.
Gilman S, et al. Cerebral cortical and subcortical cholinergic deficits in Parkinsonian syndromes. Neurology. 2010;74(18):1416–23.
Harlein J, et al. Fall risk factors in older people with dementia or cognitive impairment: a systematic review. J Adv Nurs. 2009;65(5):922–33.
Hill KD, et al. Effectiveness of balance training exercise in people with mild to moderate severity Alzheimer’s disease: protocol for a randomised trial. BMC Geriatr. 2009;9:29.
Hippisley-Cox J, Coupland C. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ. 2012;344:e3427–43.
Honjo K, Black SE, Verhoeff NP. Alzheimer’s disease, cerebrovascular disease, and the beta-amyloid cascade. Can J Neurol Sci. 2012;39(6):712–28.
Imamura T, et al. Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer’s disease. Eur J Neurol. 2000;7(1):77–9.
Inzitari M, et al. Cerebrovascular disease and gait and balance impairment in mild to moderate Alzheimer’s disease. J Nutr Health Aging. 2013;17(1):45–8.
Ishizaki F, et al. Relationship between osteopenia and clinical characteristics of Parkinson’s disease. Mov Disord. 1993;8(4):507–11.
Jenkinson N, et al. Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus. Mov Disord. 2009;24(3):319–28.
Kafri M, et al. High-level gait disorder: associations with specific white matter changes observed on advanced diffusion imaging. J Neuroimaging. 2013;23(1):39–46.
Kallin K, Gustafson Y, Lundin-Olsson L. Factors associated with falls among older, cognitively impaired people in geriatric care settings. Am J Geriatr Psychiatry. 2005;13:501–9.
Kanis JA, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385–97.
Karachi C, et al. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest. 2010;120(8):2745–54.
Kerr G, et al. Predictors of future falls in Parkinson disease. Neurology. 2010;75(2):116–24.
Kröpelin TF, et al. Fall determinants in older long-term care residents with dementia: a systematic review. Int Psychogeriatr. 2013;25(04):549–63.
LADIS study group et al. 2001-2011: A decade of the LADIS (Leukoaraiosis and DISability) study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis. 2011;32(6):577–88.
Latt M, et al. Clinical and physiological assessments for elucidating falls risk in Parkinson’s disease. Mov Disord. 2009;24(9):1280–9.
Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47(1):40–50.
Lim I, et al. Identifying fallers with Parkinson’s disease using home-based tests: who is at risk? Mov Disord. 2008;23(16):2411–5.
Lord S, Menz H, Tiedemann A. A physiological profile approach to falls risk assessment and prevention. Phys Ther. 2003;83:237–52.
Lord S, et al. Executive dysfunction and attention contribute to gait interference in ‘off’ state Parkinson’s disease. Gait Posture. 2010;31(2):169–74.
Lord S, et al. Gait variability in Parkinson’s disease: an indicator of non-dopaminergic contributors to gait dysfunction? J Neurol. 2011a;258(4):566–72.
Lord S, et al. Attention rather than spatial memory predicts distinct characteristics of Parkinson’s disease. Mov Disord. 2011b;26(Suppl2):S392–424.
Lowery K, et al. Depression in the carers of dementia sufferers: a comparison of the carers of patients suffering from dementia with Lewy bodies and the carers of patients with Alzheimer’s disease. J Affect Disord. 2000a;59(1):61–5.
Lowery K, Buri H, Ballard C. What is the prevalence of environmental hazards in the homes of dementia sufferers and are they associated with falls. Int J Geriatr Psychiatry. 2000b;15(10):883–6.
Lundin-Olsson L, Nyberg L, Gustafson Y. “Stops walking when talking” as a predictor of falls in elderly people. Lancet. 1997;349(9052):617.
McKeith I, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 2000;54(5):1050–8.
Melton 3rd LJ, et al. Fracture risk after the diagnosis of Parkinson’s disease: influence of concomitant dementia. Mov Disord. 2006;21(9):1361–7.
Montero-Odasso M, Wells J, Borrie M. Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls. J Am Geriatr Soc. 2009;57(2):359–60.
Montero-Odasso M, et al. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc. 2012;60(11):2127–36.
Morris J, et al. Senile dementia of the Alzheimer’s type: an important risk factor for serious falls. J Gerontol. 1987;42:412–7.
Morrison R, Siu A. Mortality from pneumonia and hip fractures in patients with advanced dementia. JAMA. 2000;284(19):2447–8.
Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf. 2002;11(2):97–104.
Oliver D, et al. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ. 2007;334(7584):82.
Robinson K, et al. Falling risk factors in Parkinson’s disease. NeuroRehabilitation. 2005;20(3):169–82.
Rochester L, et al. Walking speed during single and dual tasks in Parkinson’s disease: which characteristics are important? Mov Disord. 2008;23(16):2312–8.
Rochester L, et al. Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease. Brain. 2012;135(Pt 9):2779–88.
Rosano C, et al. Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults. Neuroepidemiology. 2006;26(1):52–60.
Salva A, et al. Falls and risk factors for falls in community-dwelling adults with dementia (NutriAlz trial). Alzheimer Dis Assoc Disord. 2012;26(1):74–80.
Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson’s disease. Neurology. 1997;49(5):1273–8.
Scandol J, Toson B, Close J. Fall-related hip fracture hospitalisations and the prevalence of dementia within older people in New South Wales, Australia: an analysis of linked data. Injury. 2013;44(6):776–83.
Schwenk M, et al. Dual-task performances can be improved in patients with dementia: a randomized controlled trial. Neurology. 2010;74(24):1961–8.
Shaw FE. Falls in cognitive impairment and dementia. Clin Geriatr Med. 2002;18(2):159–73.
Shaw FE. Prevention of falls in older people with dementia. J Neural Transm. 2007;114(10):1259–64.
Sheahan SL, et al. Psychoactive medication, alcohol-use, and falls among older adults. J Behav Med. 1995;18(2):127–40.
Sherrington C, et al. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc. 2008;56(12):2234–43.
Shimada H, et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology. 2009;73(4):273–8.
Snijders AH, et al. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol. 2007;6(1):63–74.
Srikanth V, et al. Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study. Stroke. 2009;40(1):175–80.
Stenvall M, et al. A multidisciplinary intervention program improved the outcome after hip fracture for people with dementia–subgroup analyses of a randomized controlled trial. Arch Gerontol Geriatr. 2012;54(3):e284–9.
Taylor ME, et al. Gait impairment and falls in cognitively impaired older adults: an explanatory model of sensorimotor and neuropsychological mediators. Age Ageing. 2012;41(5):665–9.
Tinetti M, Speechley M, Ginter S. Risk factors for falls among elderly people living in the community. N Engl J Med. 1988;319:1701–7.
van Iersel MB, et al. Systematic review of quantitative clinical gait analysis in patients with dementia. Z Gerontol Geriatr. 2004;37(1):27–32.
Verghese J, et al. Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc. 2006;54(2):255–61.
Verghese J, et al. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry. 2007;78(9):929–35.
Voisin T, et al. Predictive factors of hospitalizations in Alzheimer’s disease: a two-year prospective study in 686 patients of the REAL.FR study. J Nutr Health Aging. 2010;14(4):288–91.
Wiles MD, et al. Nottingham Hip Fracture Score as a predictor of one year mortality in patients undergoing surgical repair of fractured neck of femur. Br J Anaesth. 2011;106(4):501–4.
Williams DR, Watt HC, Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry. 2006;77(4):468–73.
World Health Organisation. Violence and injury prevention and disability-falls. 2013. http://www.who.int/violence_injury_prevention_other_injury/falls/en/.
World Health Organisation. Global Health and Ageing. 2011. http://who.int/ageing/publications/global_health/en/.
Yarnall A, Rochester L, Burn DJ. The interplay of cholinergic function, attention, and falls in Parkinson’s disease. Mov Disord. 2011;26(14):2496–503.
Yogev-Seligmann G, et al. Dual tasking, gait rhythmicity, and Parkinson’s disease: which aspects are attention demanding. Eur J Neurosci. 2005;22:124–1256.
Zheng JJ, et al. Impact of white matter lesions on physical functioning and fall risk in older people: a systematic review. Stroke. 2011;42(7):2086–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Rochester, L., Lord, S., Yarnall, A.J., Burn, D.J. (2014). Falls in Patients with Dementia. In: Merello, M., Starkstein, S. (eds) Movement Disorders in Dementias. Springer, London. https://doi.org/10.1007/978-1-4471-6365-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6365-7_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6364-0
Online ISBN: 978-1-4471-6365-7
eBook Packages: MedicineMedicine (R0)